Navigation Links
Symposium highlights epigenetic effects of milk
Date:4/5/2013

It seems the ads were right. A milk mustache is a good thing to have. Animal and dairy scientists have discovered that drinking milk at an early age can help mammals throughout their lives.

But understanding exactly how milk affects the body is a complicated story of hormones, antibodies and proteins, as well as other cells and compounds researchers have not yet identified.

Learning how milk affects offspring was the subject of the Lactation Biology Symposium, held as part of the 2012 Joint Annual Meeting in Phoenix, AZ. The presentations were summarized in a recent paper in the Journal of Animal Science.

The presentations focused on epigenetics, or how gene expression changes based on factors like environment or diet. Epigenetic changes modify when or how certain traits are expressed.

The first presenter, Dr. Frank Bartol from Auburn University, explained how certain hormones, called lactocrines, in pig's milk affect gene expression in piglets. Bartol said lactrocrines could modify gene expression in the reproductive systems; however, Bartol said the specific effects of lactocrines are still being studied.

In the next presentation, Dr. Harald Hammon, from the Leibniz Institute for Farm Animal Biology, explained how drinking milk affects future nutrition. According to Hammon, the milk produced in the first few days after birth, called colostrum, contains growth factors that help young calves better digest and absorb lactose and glucose. Hammon called for more research into identifying these factors and better describing their effects.

Studying milk is important not just for studying future fertility and nutrition, but future milk production as well. Dr. Paul Kenyon, from Massey University in New Zealand, suggested that either underfeeding or overfeeding milk could reduce milk production in the offspring. Though the differences in milk yield were small, there could still be an economic difference for d
'/>"/>

Contact: Madeline McCurry-Schmidt
madelinems@asas.org
217-689-2435
American Society of Animal Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. 5th Annual Advances in Biomolecular Engineering Symposium
2. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
3. Coral reef experts to present latest coral reef science during July symposium
4. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
5. Topics to be discussed during July International Coral Reef Symposium
6. MARC Travel Awards announced for the 26th Annual Symposium of the Protein Society
7. The genomics symposium to boost the further development of cancer research
8. 12th International Coral Reef Symposium
9. Symposium: Protein-Folding Diseases: Models & Mechanisms
10. FDAs 2012 Science Writers Symposium
11. Danforth Plant Science Center hosts 14th Annual Fall Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
(Date:7/24/2014)... Scientists at The New York Stem Cell Foundation ... creating a viable cell replacement therapy for multiple ... For the first time, NYSCF scientists generated induced ... of patients with primary progressive multiple sclerosis and ... these stem cells into becoming oligodendrocytes, the myelin-forming ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... DENVER (Feb. 21, 2013) A new study from the ... practices in Eurasia varied widely, with some graves lavish and ... don,t know why some of these burials were so ornate, ... modern humans in Europe by almost 10,000 years," said Julien ...
... SOLOMONS, MD (February 21, 2013)--Biologists Jackie Grebmeier and Lee Cooper ... Biological Laboratory have been visiting the chilly area north of ... but it,s only in the last few years that they ... summer was the highest ice retreat in the Arctic record, ...
... NY, February 20, 2013As the nations of the world ... in endangered sharks in early March, a team of ... the oceanic whitetip shark regularly crosses international boundaries. ... predator within their own maritime borders may therefore need ...
Cached Biology News:Early human burials varied widely but most were simple 2Early human burials varied widely but most were simple 3Biologists lead international team to track Arctic response to climate change 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 3
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
(Date:7/24/2014)... WIRB-Copernicus Group ® ("WCG")™, the ... services for clinical research, announced today that it ... Richmond, VA -based Alliance Engineering, ... consulting firm in the United States ... – WCG Biosafety™ – will be able to ...
(Date:7/24/2014)... Toronto, Canada (PRWEB) July 24, 2014 ... for Optimizing Dose Escalation in First in Human Studies” ... to make better go/no-go decisions. , With increasing R&D ... market, pharmaceutical companies need to maximize the knowledge collected ... go/no-go decisions and improve success in late stage development. ...
(Date:7/24/2014)...  Spherix Incorporated (SPEX) -- an intellectual property development ... property, today announced that the Company will issue a ... on Monday, August 18, 2014 for shareholders. Management has ... Monday, August 18, 2014 to discuss the company,s progress ... Anthony Hayes . Following prepared remarks, ...
Breaking Biology Technology:Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Spherix Schedules Shareholder Update Call 2
... Companies Also Sign Manufacturing and Distribution Agreement, ... 15 Ranbaxy,Pharmaceuticals Inc. (RPI), a wholly ... today that it has reached several,agreements with ... capsules. The third agreement pertains to Omeprazole ...
... Symbol: MS, EDMONTON, April 15 /PRNewswire-FirstCall/ - ... the treatment of multiple sclerosis (MS), today,announced that ... data from the Company,s on-going MAESTRO-03 U.S. pivotal ... of secondary progressive MS and,recommended that the trial ...
... 15 Emisphere,Technologies, Inc. (Nasdaq: EMIS ), ... Meeting on Thursday, May 8, 2008, at the ... New Jersey. The,meeting will begin at 10:00 a.m. ... Technologies, Inc. is a biopharmaceutical company that,focuses on ...
Cached Biology Technology:Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 2Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 3BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2
Human SIGIRR MAb (Clone 162201)...
... 1. 1000 V, 400 mA, 100 ... constant power modes.Single-unit increments in settings ... and recalls three protocols.Outstanding choice for ... Multiphor II or GenePhor systems. Category: ...
Mouse Serpin F1/PEDF MAb (Clone 199315)...
Mouse Nodal Affinity Purified Polyclonal Ab...
Biology Products: